US appeals court upholds AstraZeneca’s Seroquel XR patent


The US Court of Appeals for the Federal Circuit has affirmed a 2012 ruling that AstraZeneca’s patent for blockbuster antipsychotic drug Seroquel XR is valid and has been infringed by companies selling competing generics.

AstraZeneca, Seroquel XR, Mylan, Torrent, Osmotica, infringement